(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HEPCLUDEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

HEPCLUDEX

ST13

US500000079279863

Class

5

Filing

79279863

Registration

6235919

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

01/06/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

12/27/2019

Registration date

01/05/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/05/2021

Last transaction

01/06/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

27

Owner location

DE

Examiner

DYER,ERIN ZASKODA

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

MYR GmbH

Representatives

Megan K. Bowen Edell, Shapiro & Finnan, LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary preparations in the nature of diagnostic preparations for veterinary and medical purposes; biological preparations for medical purposesfor the treatment of cancer; biological preparations for veterinary purposesfor the treatment of intestinal bacteria; biochemical preparations for medical purposesfor treating chemical imbalances; biochemical preparations for veterinary purposesnucleic acid sequences and chemical reagents for veterinary purposes; chemical preparations for medical purposesfor diagnosis of pregnancy; chemical preparations for veterinary purposes in the nature of chemical reagents for veterinary purposes; medicines for human purposesfor treating intestinal disorders; medicines for veterinary purposesfor treating intestinal disorders; pharmaceutical preparations for the treatment of hepatic diseases or disorders; pharmaceutical preparations for the treatment of hepatitis B; pharmaceutical preparations for the treatment of hepatitis D; pharmaceutical preparations for the treatment of dyslipidemia; pharmaceutical preparations for the treatment of nonalcoholic steatohepatitis (NASH); pharmaceutical preparations for the treatment of primary biliary cholangitis (PBC); pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide (NTCP); pharmaceutical preparations for the treatment of metabolic diseases; and pharmaceutical preparations for the treatment of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide (NTCP)

Publications

History of USPTO decisions and trademark events.

39 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/05/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/12/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

05/27/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/06/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/02/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/02/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/08/2021

FIMP

FINAL DISPOSITION PROCESSED

04/08/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/05/2021

CORR

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

03/01/2021

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

02/20/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

01/22/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

01/05/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/20/2020

PUBO

PUBLISHED FOR OPPOSITION

10/20/2020

GPNX

NOTIFICATION PROCESSED BY IB

10/18/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/30/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/30/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/30/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/16/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/26/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/25/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/25/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/17/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/17/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

08/17/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/17/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/17/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/17/2020

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/24/2020

RFNT

REFUSAL PROCESSED BY IB

05/01/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/13/2020

RFRR

REFUSAL PROCESSED BY MPU

04/13/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/26/2020

CNRT

NON-FINAL ACTION WRITTEN

03/25/2020

DOCK

ASSIGNED TO EXAMINER

03/21/2020

MAFR

APPLICATION FILING RECEIPT MAILED

03/06/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/02/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/27/2020

Continuous trademark protection

Get notified about every new filing that threatens HEPCLUDEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.